{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:30:40Z","timestamp":1790188240372,"version":"4.1.0"},"reference-count":236,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mechanisms of Ageing and Development"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.mad.2024.111961","type":"journal-article","created":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T04:52:53Z","timestamp":1719895973000},"page":"111961","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["New opportunities for antioxidants in amelioration of neurodegenerative diseases"],"prefix":"10.1016","volume":"221","author":[{"given":"Uttam Raj","family":"Bhandari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Mohammad","family":"Danish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shadaan","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Ikram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arif","family":"Nadaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazeer","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashant","family":"Kesharwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhan J.","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mad.2024.111961_bib1","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S1474-4422(17)30115-1","article-title":"Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial","volume":"16","author":"Abe","year":"2017","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.mad.2024.111961_bib2","doi-asserted-by":"crossref","first-page":"610","DOI":"10.3109\/21678421.2014.959024","article-title":"Confirmatory double-blind, parallel-group, placebo-controlled study of efficacy and safety of edaravone (MCI-186) in amyotrophic lateral sclerosis patients","volume":"15","author":"Abe","year":"2014","journal-title":"Amyotroph. Lateral Scler. Front. Degener."},{"key":"10.1016\/j.mad.2024.111961_bib3","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/jnr.10349","article-title":"Remarkable increase in the concentration of 8-hydroxyguanosine in cerebrospinal fluid from patients with Alzheimer\u2019s disease","volume":"70","author":"Abe","year":"2002","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.mad.2024.111961_bib4","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.biocel.2008.06.010","article-title":"Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases","volume":"41","author":"Aggarwal","year":"2009","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.mad.2024.111961_bib5","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.jocn.2021.03.047","article-title":"Effects of vitamin B12, folate, and entacapone on homocysteine levels in levodopa-treated Parkinson \u2019 s disease patients: A randomized controlled study","volume":"88","author":"Anamnart","year":"2021","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.mad.2024.111961_bib6","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/alz.12068","article-title":"2020 Alzheimer\u2019s disease facts and figures","volume":"16","author":"Anone","year":"2020","journal-title":"Alzheimer\u2019S. Dement"},{"key":"10.1016\/j.mad.2024.111961_bib7","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/alz.12328","article-title":"2021 Alzheimer\u2019s disease facts and figures","volume":"17","author":"Anone","year":"2021","journal-title":"Alzheimer\u2019S. Dement"},{"key":"10.1016\/j.mad.2024.111961_bib8","doi-asserted-by":"crossref","first-page":"5950","DOI":"10.1073\/pnas.2628045100","article-title":"A cell-based assay for aggregation inhibitors as therapeutics of polyglutamine-repeat disease and validation in Drosophila","volume":"100","author":"Apostol","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mad.2024.111961_bib9","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s10522-022-09973-y","article-title":"Mitochondria-targeted senotherapeutic interventions","volume":"23","author":"Atayik","year":"2022","journal-title":"Biogerontology"},{"key":"10.1016\/j.mad.2024.111961_bib10","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10522-023-10055-w","article-title":"Redox signaling and modulation in ageing","volume":"24","author":"Atayik","year":"2023","journal-title":"Biogerontology"},{"key":"10.1016\/j.mad.2024.111961_bib11","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jns.2011.03.041","article-title":"A novel codon4 mutation (A4F) in the SOD1gene in familial amyotrophic lateral sclerosis","volume":"306","author":"Baek","year":"2011","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.mad.2024.111961_bib12","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1159\/000069994","article-title":"Profile of neuropsychological deficits in older stroke survivors without dementia","volume":"16","author":"Ballard","year":"2003","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.mad.2024.111961_bib13","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.freeradbiomed.2009.11.018","article-title":"Oxidative stress in ALS: Key role in motor neuron injury and therapeutic target","volume":"48","author":"Barber","year":"2010","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.mad.2024.111961_bib14","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/nrd2060","article-title":"Therapeutic potential of resveratrol: The in vivo evidence","volume":"5","author":"Baur","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.mad.2024.111961_bib15","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2337\/diab.40.4.405","article-title":"Role of oxidative stress in development of complications in diabetes","volume":"40","author":"Baynes","year":"1991","journal-title":"Diabetes"},{"key":"10.1016\/j.mad.2024.111961_bib16","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1073\/pnas.87.4.1620","article-title":"Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide","volume":"87","author":"Beckman","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mad.2024.111961_bib17","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1152\/physrev.00044.2005","article-title":"The NOX family of ROS-generating NADPH oxidases: Physiology and pathophysiology","volume":"87","author":"Bedard","year":"2007","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.mad.2024.111961_bib18","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1046\/j.1471-4159.2003.01883.x","article-title":"Localization of the RNA-binding proteins Staufenl and Staufen2 at the mammalian neuromuscular junction","volume":"86","author":"B\u00e9langer","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.mad.2024.111961_bib19","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1161\/01.RES.83.2.117","article-title":"Stress (heat shock) proteins molecular chaperones in cardiovascular biology and disease","volume":"83","author":"Benjamin","year":"1998","journal-title":"Circ. Res."},{"key":"10.1016\/j.mad.2024.111961_bib20","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/81834","article-title":"Chronic systemic pesticide exposure reproduces features of Parkinson\u2019s disease","volume":"3","author":"Betarbet","year":"2000","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.mad.2024.111961_bib21","first-page":"273","article-title":"Low-Cost, 3-dimension, office-based inertial sensors for automated tremor assessment: Technical development and experimental verification","volume":"4","author":"Bhidayasiri","year":"2014","journal-title":"J. Park. Dis."},{"key":"10.1016\/j.mad.2024.111961_bib22","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1084\/jem.20080178","article-title":"A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington\u2019s disease","volume":"205","author":"Bj\u00f6rkqvist","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.mad.2024.111961_bib23","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1046\/j.1471-4159.2001.00689.x","article-title":"Increased oxidative damage to DNA in a transgenic mouse model of Huntington\u2019s disease","volume":"79","author":"Bogdanov","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.mad.2024.111961_bib24","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/S0891-5849(00)00349-X","article-title":"Increased oxidative damage to DNA in ALS patients","volume":"29","author":"Bogdanov","year":"2000","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.mad.2024.111961_bib25","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jalz.2007.04.381","article-title":"Forecasting the global burden of Alzheimer\u2019s disease","volume":"3","author":"Brookmeyer","year":"2007","journal-title":"Alzheimer\u2019S. Dement"},{"key":"10.1016\/j.mad.2024.111961_bib26","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0301-0082(99)00005-2","article-title":"Replicating Huntington\u2019s disease phenotype in experimental animals","volume":"59","author":"Brouillet","year":"1999","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.mad.2024.111961_bib27","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/S0891-5849(02)01112-7","article-title":"Nitric oxide inhibition of mitochondrial respiration and its role in cell death","volume":"33","author":"Brown","year":"2002","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.mad.2024.111961_bib28","doi-asserted-by":"crossref","unstructured":"A. Browne, Beal, Htt Protein and Disease Pathogenesis, 8 (2006).","DOI":"10.1089\/ars.2006.8.2061"},{"key":"10.1016\/j.mad.2024.111961_bib29","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/ana.410410514","article-title":"Oxidative damage and metabolic dysfunction in huntington\u2019s disease: Selective vulnerability of the basal ganglia","volume":"41","author":"Browne","year":"1997","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.mad.2024.111961_bib30","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.3233\/JAD-170543","article-title":"Oxidative Stress, Amyloid-\u03b2 Peptide, and Altered Key Molecular Pathways in the Pathogenesis and Progression of Alzheimer\u2019s Disease","volume":"62","author":"Butterfield","year":"2018","journal-title":"J. Alzheimer\u2019S. Dis."},{"key":"10.1016\/j.mad.2024.111961_bib31","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/s41583-019-0132-6","article-title":"Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease","volume":"20","author":"Butterfield","year":"2019","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.mad.2024.111961_bib32","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/S0891-5849(02)00794-3","article-title":"Lipid peroxidation and protein oxidation in Alzheimer\u2019s disease brain: Potential causes and consequences involving amyloid \u03b2-peptide-associated free radical oxidative stress","volume":"32","author":"Butterfield","year":"2002","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.mad.2024.111961_bib33","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0027-5107(99)00004-4","article-title":"Hydroxyl radicals and DNA base damage","volume":"424","author":"Cadet","year":"1999","journal-title":"Mutat. Res. - Fundam. Mol. Mech. Mutagen."},{"key":"10.1016\/j.mad.2024.111961_bib34","first-page":"1","article-title":"Oxidative stress and mitochondrial damage: Importance in non-SOD1 ALS","volume":"9","author":"Carr\u00ec","year":"2015","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.mad.2024.111961_bib35","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.neurobiolaging.2016.08.019","article-title":"Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly","volume":"49","author":"Cattaneo","year":"2017","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.mad.2024.111961_bib36","doi-asserted-by":"crossref","first-page":"279","DOI":"10.14573\/altex.1310071","article-title":"Animal models of Alzheimer disease: Historical pitfalls and a path forward","volume":"31","author":"Cavanaugh","year":"2014","journal-title":"ALTEX"},{"key":"10.1016\/j.mad.2024.111961_bib37","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.pneurobio.2006.11.001","article-title":"The corticostriatal pathway in Huntington\u2019s disease","volume":"81","author":"Cepeda","year":"2007","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.mad.2024.111961_bib38","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1039\/C6MT00150E","article-title":"Metal-catalyzed oxidation of A\u03b2 and the resulting reorganization of Cu binding sites promote ROS production","volume":"8","author":"Cheignon","year":"2016","journal-title":"Metallomics"},{"key":"10.1016\/j.mad.2024.111961_bib39","first-page":"135","article-title":"Mitochondrial dysfunction, metabolic deficits, and increased oxidative stress in huntington\u2019s disease","volume":"34","author":"Chen","year":"2011","journal-title":"Chang Gung Med. J."},{"key":"10.1016\/j.mad.2024.111961_bib40","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.nbd.2008.11.011","article-title":"Increased oxidative damage in peripheral blood correlates with severity of Parkinson\u2019s disease","volume":"33","author":"Chen","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.mad.2024.111961_bib41","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/jnc.12046","article-title":"S-nitrosylated protein disulfide isomerase contributes to mutant SOD1 aggregates in amyotrophic lateral sclerosis","volume":"124","author":"Chen","year":"2013","journal-title":"J. Neurochem."},{"key":"10.1016\/j.mad.2024.111961_bib42","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/0166-2236(95)80018-W","article-title":"Calcium: still center-stage in hypoxic-ischemic neuronal death","volume":"18","author":"Choi","year":"1995","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.mad.2024.111961_bib43","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1093\/hmg\/ddh162","article-title":"Mutant huntingtin directly increases susceptibility of mitochondria to the calcium-induced permeability transition and cytochrome c release","volume":"13","author":"Choo","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.mad.2024.111961_bib44","doi-asserted-by":"crossref","first-page":"7151","DOI":"10.1093\/emboj\/17.24.7151","article-title":"The ubiquitin-proteasome pathway: On protein death and cell life","volume":"17","author":"Ciechanover","year":"1998","journal-title":"EMBO J."},{"key":"10.1016\/j.mad.2024.111961_bib45","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/nrn2935","article-title":"The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson\u2019s disease","volume":"11","author":"Cookson","year":"2010","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.mad.2024.111961_bib46","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/s41573-018-0008-x","article-title":"Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases","volume":"18","author":"Cuadrado","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.mad.2024.111961_bib47","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1038\/nm.2579","article-title":"The effects of dexpramipexole (KNS-760704) in individuals with amyotrophic lateral sclerosis","volume":"17","author":"Cudkowicz","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.mad.2024.111961_bib48","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1111\/j.1471-4159.2006.03619.x","article-title":"Neural mitochondrial Ca2+ capacity impairment precedes the onset of motor symptoms in G93A Cu\/Zn-superoxide dismutase mutant mice","volume":"96","author":"Damiano","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.mad.2024.111961_bib49","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/mds.1091","article-title":"Chronic L-DOPA administration is not toxic to the remaining dopaminergic nigrostriatal neurons, but instead may promote their functional recovery, in rats with partial 6-OHDA or FeCl3 nigrostriatal lesions","volume":"16","author":"Datla","year":"2001","journal-title":"Mov. Disord."},{"key":"10.1016\/j.mad.2024.111961_bib50","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0079-6123(08)63210-0","article-title":"Nitric oxide in neurodegeneration","volume":"118","author":"Dawson","year":"1998","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.mad.2024.111961_bib51","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1006\/neur.1996.0056","article-title":"Structural correlates of cognition in dementia: Quantification and assessment of synapse change","volume":"5","author":"DeKosky","year":"1996","journal-title":"Neurodegeneration"},{"key":"10.1016\/j.mad.2024.111961_bib52","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/S0140-6736(87)91361-4","article-title":"Increased Nigral Iron Content in Postmortem Parkinsonian Brain","volume":"330","author":"Dexter","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.mad.2024.111961_bib53","first-page":"461","article-title":"The role of oxidative stress in parkinson\u2019s disease","volume":"3","author":"Dias","year":"2013","journal-title":"J. Park. Dis."},{"issue":"80","key":"10.1016\/j.mad.2024.111961_bib54","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","article-title":"Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain","volume":"277","author":"DiFiglia","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.mad.2024.111961_bib55","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s00702-018-1880-6","article-title":"Neuroinflammation in neurodegeneration: role in pathophysiology, therapeutic opportunities and clinical perspectives","volume":"125","author":"Doroth\u00e9e","year":"2018","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.mad.2024.111961_bib56","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.4103\/1673-5374.300980","article-title":"Oxidative stress factors in Parkinson\u2019s disease","volume":"16","author":"Dorszewska","year":"2021","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.mad.2024.111961_bib57","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1001\/jama.2013.282834","article-title":"Effect of vitamin E and memantine on functional decline in Alzheimer disease: The TEAM-AD VA cooperative randomized trial","volume":"311","author":"Dysken","year":"2014","journal-title":"Jama"},{"key":"10.1016\/j.mad.2024.111961_bib58","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/s41593-018-0332-9","article-title":"Mitophagy inhibits amyloid-\u03b2 and tau pathology and reverses cognitive deficits in models of Alzheimer\u2019s disease","volume":"22","author":"Fang","year":"2019","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.mad.2024.111961_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110234","article-title":"The therapeutic effect of resveratrol: Focusing on the Nrf2 signaling pathway","volume":"127","author":"Farkhondeh","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.mad.2024.111961_bib60","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1046\/j.1471-4159.1997.69052064.x","article-title":"Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis","volume":"69","author":"Ferrante","year":"1997","journal-title":"J. Neurochem."},{"key":"10.1016\/j.mad.2024.111961_bib61","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0955-0674(03)00002-4","article-title":"Oxidant signals and oxidative stress","volume":"15","author":"Finkel","year":"2003","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.mad.2024.111961_bib62","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.freeradbiomed.2016.07.003","article-title":"Redox signaling: An evolution from free radicals to aging","volume":"97","author":"Forman","year":"2016","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.mad.2024.111961_bib63","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/ncpcardio1211","article-title":"Oxidative stress in vascular disease: Causes, defense mechanisms and potential therapies","volume":"5","author":"F\u00f6rstermann","year":"2008","journal-title":"Nat. Clin. Pract. Cardiovasc. Med."},{"key":"10.1016\/j.mad.2024.111961_bib64","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1523\/JNEUROSCI.0295-20.2020","article-title":"Oxidative damage and antioxidant response in frontal cortex of demented and nondemented individuals with alzheimer\u2019s neuropathology","volume":"41","author":"Fracassi","year":"2021","journal-title":"J. Neurosci."},{"key":"10.1016\/j.mad.2024.111961_bib65","first-page":"239","article-title":"Superoxide Radical and Superoxide Dimutases","author":"Fridovich","year":"1995","journal-title":"Ann. Rev. Pharm. Toxicol."},{"key":"10.1016\/j.mad.2024.111961_bib66","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.2147\/DDDT.S235969","article-title":"Chlorogenic acid alleviates A\u03b225-35-induced autophagy and cognitive impairment via the mTOR\/TFEB signaling pathway","volume":"14","author":"Gao","year":"2020","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.mad.2024.111961_bib67","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0304-3940(99)00578-9","article-title":"Oxidative damage to mitochondrial DNA in Huntington\u2019s disease parietal cortex","volume":"272","author":"Gemba","year":"1999","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.mad.2024.111961_bib68","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-4615-0123-7_1","article-title":"Excitatory amino acid neurotoxicity","volume":"513","author":"Gillessen","year":"2002","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.mad.2024.111961_bib69","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/hmg\/ddg046","article-title":"Specific progressive cAMP reduction implicates energy deficit in presymptomatic Huntington\u2019s disease knock-in mice","volume":"12","author":"Gines","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.mad.2024.111961_bib70","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.cell.2010.02.016","article-title":"Mechanisms Underlying Inflammation in Neurodegeneration","volume":"140","author":"Glass","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.mad.2024.111961_bib71","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S1474-4422(21)00414-2","article-title":"Emerging insights into the complex genetics and pathophysiology of amyotrophic lateral sclerosis","volume":"21","author":"Goutman","year":"2022","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.mad.2024.111961_bib72","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/PL00022909","article-title":"MPTP and 6-hydroxydopamine-induced neurodegeneration as models for Parkinson\u2019s disease: Neuroprotective strategies","volume":"Suppl. 247","author":"Gr\u00fcnblatt","year":"2000","journal-title":"J. Neurol."},{"issue":"80","key":"10.1016\/j.mad.2024.111961_bib73","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1126\/science.8209258","article-title":"Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation","volume":"264","author":"Gurney","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.mad.2024.111961_bib74","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/ana.410370604","article-title":"Low platelet mitochondrial complex I and complex II\/III activity in early untreated parkinson\u2019s disease","volume":"37","author":"Haas","year":"1995","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.mad.2024.111961_bib75","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nature13124","article-title":"C9orf72 nucleotide repeat structures initiate molecular cascades of disease","volume":"507","author":"Haeusler","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.mad.2024.111961_bib76","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1104\/pp.106.077073","article-title":"Reactive species and antioxidants. Redox biology is a fundamental theme of aerobic life","volume":"141","author":"Halliwell","year":"2006","journal-title":"Plant Physiol."},{"key":"10.1016\/j.mad.2024.111961_bib77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj2190001","article-title":"Oxygen toxicity, oxygen radicals, transition metals and disease","volume":"219","author":"Halliwell","year":"1984","journal-title":"Biochem. J."},{"key":"10.1016\/j.mad.2024.111961_bib78","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0076-6879(90)86093-B","article-title":"Role of free radicals and catalytic metal ions in human disease: An overview","volume":"186","author":"Halliwell","year":"1990","journal-title":"Methods Enzym."},{"key":"10.1016\/j.mad.2024.111961_bib79","doi-asserted-by":"crossref","unstructured":"E. Hanan, N. Hasan, S. Zahiruddin, S. Ahmad, V. Sharma, F.J. Ahmad, Utilization of Quince <italic toggle=\"yes\">(Cydonia oblonga)<\/italic> Peel and Exploration of Its Metabolite Profiling and Cardioprotective Potential Against Doxorubicin-Induced Cardiotoxicity in Wistar Rats, ACS Omega. 0 (n.d.) null-null. \u3008https:\/\/doi.org\/10.1021\/acsomega.3c00698\u3009.","DOI":"10.1021\/acsomega.3c00698"},{"key":"10.1016\/j.mad.2024.111961_bib80","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/wrna.111","article-title":"RNA-binding proteins in neurodegenerative disease: TDP-43 and beyond","volume":"3","author":"Hanson","year":"2012","journal-title":"Wiley Interdiscip. Rev. Rna"},{"key":"10.1016\/j.mad.2024.111961_bib81","doi-asserted-by":"crossref","first-page":"5360","DOI":"10.1073\/pnas.88.12.5360","article-title":"The aging process: Major risk factor for disease and death","volume":"88","author":"Harman","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mad.2024.111961_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122580","article-title":"Formulation and development of novel lipid-based combinatorial advanced nanoformulation for effective treatment of non-melanoma skin cancer","author":"Hasan","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.mad.2024.111961_bib83","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1080\/1061186X.2022.2056188","article-title":"Cannabis as a potential compound against various malignancies, legal aspects, advancement by exploiting nanotechnology and clinical trials","volume":"30","author":"Hasan","year":"2022","journal-title":"J. Drug Target."},{"key":"10.1016\/j.mad.2024.111961_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2023.116454","article-title":"Advanced multifunctional nano-lipid carrier loaded gel for targeted delivery of 5-flurouracil and cannabidiol against non-melanoma skin cancer","volume":"233","author":"Hasan","year":"2023","journal-title":"Environ. Res."},{"key":"10.1016\/j.mad.2024.111961_bib85","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s12943-023-01854-3","article-title":"Skin cancer: understanding the journey of transformation from conventional to advanced treatment approaches","volume":"22","author":"Hasan","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.mad.2024.111961_bib86","doi-asserted-by":"crossref","unstructured":"Heneka, M.T., Carson, M.J., Khoury, J.El, Landreth, G.E., Brosseron, F., Feinstein, D.L., Jacobs, A.H., Wyss-coray, T., Vitorica, J., Ransohoff, R.M., Herrup, K., Frautschy, S.A., Finsen, B., Brown, G.C., Verkhratsky, A., Yamanaka, K., Koistinaho, J., Latz, E., Halle, A., Petzold, G.C., Town, T., Morgan, D., Shinohara, M.L., Perry, V.H., Holmes, C., Bazan, N.G., Brooks, D.J., Hunot, S., Joseph, B., Deigendesch, N., Garaschuk, O., Boddeke, E., Dinarello, C.A., Breitner, J.C., Cole, G.M., Golenbock, D.T., Kummer, M.P., 2015. Neuroinfl ammation in Alzheimer \u2019 s disease 14.","DOI":"10.1016\/S1474-4422(15)70016-5"},{"key":"10.1016\/j.mad.2024.111961_bib87","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in Alzheimer\u2019s disease","volume":"14","author":"Heneka","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.mad.2024.111961_bib88","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0165-5728(01)00246-6","article-title":"Expression and function of inducible nitric oxide synthase in neurons","volume":"114","author":"Heneka","year":"2001","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.mad.2024.111961_bib89","doi-asserted-by":"crossref","first-page":"3702","DOI":"10.1093\/hmg\/ddq285","article-title":"Early autophagic response in a novel knock-in model of Huntington disease","volume":"19","author":"Heng","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.mad.2024.111961_bib90","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1212\/01.wnl.0000194318.74946.b6","article-title":"Creatine in Huntington disease is safe, tolerable, bioavailable in brain and reduces serum 8OH2\u2019dG","volume":"66","author":"Hersch","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.mad.2024.111961_bib91","article-title":"Neuroinfl ammation in Parkinson \u2019 s disease: a target for neuroprotection","volume":"8","author":"Hirsch","year":"2009"},{"key":"10.1016\/j.mad.2024.111961_bib92","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1007\/s12035-014-8932-1","article-title":"Polyglutamine aggregation in huntington disease: does structure determine toxicity?","volume":"52","author":"Hoffner","year":"2015","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.mad.2024.111961_bib93","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1136\/thx.2004.031385","article-title":"Is big beautiful? The continuing story of ADAM33 and asthma","volume":"60","author":"Holgate","year":"2005","journal-title":"Thorax"},{"key":"10.1016\/j.mad.2024.111961_bib94","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1093\/brain\/awq008","article-title":"DJ-1 and \u03b1-synuclein in human cerebrospinal fluid as biomarkers of Parkinson\u2019s disease","volume":"133","author":"Hong","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.mad.2024.111961_bib95","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1004188","article-title":"MicroRNAs Located in the Hox Gene Clusters Are Implicated in Huntington\u2019s Disease Pathogenesis","volume":"10","author":"Hoss","year":"2014","journal-title":"PLoS Genet"},{"key":"10.1016\/j.mad.2024.111961_bib96","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2021.102114","article-title":"DJ-1 in neurodegenerative diseases: pathogenesis and clinical application","volume":"204","author":"Huang","year":"2021","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.mad.2024.111961_bib97","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0306-4522(95)00578-1","article-title":"Nitric oxide synthase and neuronal vulnerability in Parkinson\u2019s disease","volume":"72","author":"Hunot","year":"1996","journal-title":"Neuroscience"},{"key":"10.1016\/j.mad.2024.111961_bib98","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5607\/en.2013.22.1.11","article-title":"Role of Oxidative Stress in Parkinson\u2019s Disease","volume":"22","author":"Hwang","year":"2013","journal-title":"Exp. Neurobiol."},{"key":"10.1016\/j.mad.2024.111961_bib99","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jalz.2011.10.007","article-title":"National Institute on Aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease","volume":"8","author":"Hyman","year":"2012","journal-title":"Alzheimer\u2019S. Dement"},{"key":"10.1016\/j.mad.2024.111961_bib100","first-page":"1","author":"Imran","year":"2022","journal-title":"Unravelling chemopreventive Potential Antioxid. Var. Cancers"},{"key":"10.1016\/j.mad.2024.111961_bib101","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S0006-291X(03)00814-3","article-title":"Biological selectivity and functional aspects of protein tyrosine nitration","volume":"305","author":"Ischiropoulos","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.mad.2024.111961_bib102","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/0003-9861(92)90431-U","article-title":"Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase","volume":"298","author":"Ischiropoulos","year":"1992","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.mad.2024.111961_bib103","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1080\/21678421.2019.1645858","article-title":"Radicava (edaravone) for amyotrophic lateral sclerosis: US experience at 1 year after launch","volume":"20","author":"Jackson","year":"2019","journal-title":"Amyotroph. Lateral Scler. Front. Degener."},{"key":"10.1016\/j.mad.2024.111961_bib104","article-title":"Transferrin functionalized nanostructured lipid carriers for targeting Rivastigmine and Resveratrol to Alzheimer\u2019s disease: Synthesis, in vitro characterization and brain uptake analysis","volume":"86","author":"Jain","year":"2023","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"80","key":"10.1016\/j.mad.2024.111961_bib105","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1126\/science.275.5297.218","article-title":"Cancer chemopreventive activity of resveratrol, a natural product derived from grapes","volume":"275","author":"Jang","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.mad.2024.111961_bib106","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.47.6_Suppl_3.161S","article-title":"Oxidative stress and the pathogenesis of Parkinson\u2019s disease","volume":"47","author":"Jenner","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.mad.2024.111961_bib107","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s007020050073","article-title":"Cerebrospinal fluid levels of transition metals in patients with Parkinson\u2019s disease","volume":"105","author":"Jim\u00e9nez-Jim\u00e9nez","year":"1998","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.mad.2024.111961_bib108","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/cshperspect.a024240","article-title":"Huntington\u2019s disease: Mechanisms of pathogenesis and therapeutic strategies","volume":"7","author":"Jimenez-Sanchez","year":"2017","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.mad.2024.111961_bib109","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s10863-010-9286-7","article-title":"The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease","volume":"42","author":"Jin","year":"2010","journal-title":"J. Bioenerg. Biomembr."},{"key":"10.1016\/j.mad.2024.111961_bib110","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson\u2019s disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.mad.2024.111961_bib111","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/ana.21743","article-title":"Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III","volume":"66","author":"Kaufmann","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.mad.2024.111961_bib112","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1017\/CBO9780511581410.013","article-title":"Mild cognitive impairment","volume":"64","author":"Kelley","year":"2009","journal-title":"Behav. Neurol. Dement."},{"key":"10.1016\/j.mad.2024.111961_bib113","doi-asserted-by":"crossref","first-page":"43508","DOI":"10.1074\/jbc.M307075200","article-title":"Molecular Basis of Vitamin E Action","volume":"278","author":"Khanna","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mad.2024.111961_bib114","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S0140-6736(10)61156-7","article-title":"Amyotrophic lateral sclerosis","volume":"377","author":"Kiernan","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.mad.2024.111961_bib115","doi-asserted-by":"crossref","first-page":"3919","DOI":"10.1093\/hmg\/ddq306","article-title":"Mitochondrial loss, dysfunction and altered dynamics in Huntington\u2019s disease","volume":"19","author":"Kim","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.mad.2024.111961_bib116","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/j.cellsig.2008.07.018","article-title":"Myosin phosphatase interacts with and dephosphorylates the retinoblastoma protein in THP-1 leukemic cells: Its inhibition is involved in the attenuation of daunorubicin-induced cell death by calyculin-A","volume":"20","author":"Kiss","year":"2008","journal-title":"Cell. Signal."},{"key":"10.1016\/j.mad.2024.111961_bib117","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/33416","article-title":"Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism","volume":"392","author":"Kitada","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.mad.2024.111961_bib118","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S1474-4422(06)70537-3","article-title":"Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study","volume":"5","author":"Kivipelto","year":"2006","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.mad.2024.111961_bib119","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40478-020-01083-5","article-title":"Neuroinflammation and protein pathology in Parkinson\u2019s disease dementia","volume":"8","author":"Kouli","year":"2020","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.mad.2024.111961_bib120","first-page":"159","article-title":"ROS-induced signaling and gene expression in crops under salinity stress, React. Oxyg. Species Antioxid. Syst. Plants Role Regul","volume":"288","author":"Kumar","year":"2017","journal-title":"Abiotic Stress"},{"key":"10.1016\/j.mad.2024.111961_bib121","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.freeradbiomed.2006.05.020","article-title":"Oxidatively modified autoantigens in autoimmune diseases","volume":"41","author":"Kurien","year":"2006","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.mad.2024.111961_bib122","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0304-3940(99)00343-2","article-title":"Tremor-frequency (3\u20136\u2009Hz) activity in the sensorimotor arm representation of the internal segment of the globus pallidus in patients with Parkinson\u2019s disease","volume":"267","author":"Lemstra","year":"1999","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.mad.2024.111961_bib123","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/nm1746","article-title":"Lewy bodies in grafted neurons in subjects with Parkinson\u2019s disease suggest host-to-graft disease propagation","volume":"14","author":"Li","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.mad.2024.111961_bib124","doi-asserted-by":"crossref","unstructured":"J.R. Liddell, Are astrocytes the predominant cell type for activation of Nrf2 in aging and neurodegeneration?, 2017. \u3008https:\/\/doi.org\/10.3390\/antiox6030065\u3009.","DOI":"10.3390\/antiox6030065"},{"key":"10.1016\/j.mad.2024.111961_bib125","doi-asserted-by":"crossref","first-page":"757","DOI":"10.2147\/CIA.S158513","article-title":"Oxidative stress, aging, and diseases","volume":"13","author":"Liguori","year":"2018","journal-title":"Clin. Interv. Aging"},{"key":"10.1016\/j.mad.2024.111961_bib126","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nature05292","article-title":"Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases","volume":"443","author":"Lin","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.mad.2024.111961_bib127","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1038\/nm1106-1241","article-title":"Alzheimer\u2019s APP mangles mitochondria","volume":"12","author":"Lin","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.mad.2024.111961_bib128","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s12033-007-0052-y","article-title":"Bioenergetic and antioxidant properties of coenzyme Q10: Recent developments","volume":"37","author":"Littarru","year":"2007","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/j.mad.2024.111961_bib129","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1161\/STROKEAHA.114.007482","article-title":"MicroRNA-424 protects against focal cerebral ischemia and reperfusion injury in mice by suppressing oxidative stress","volume":"46","author":"Liu","year":"2015","journal-title":"Stroke"},{"key":"10.1016\/j.mad.2024.111961_bib130","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1093\/hmg\/11.20.2395","article-title":"P. Brundin, Impaired dopamine storage resulting from \u03b1-synuclein mutations may contribute to the pathogenesis of Parkinson\u2019s disease","volume":"11","author":"Lotharius","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.mad.2024.111961_bib131","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0197-4580(97)00108-5","article-title":"Elevated 4-hydroxynonenal in ventricular fluid in Alzheimer\u2019s disease","volume":"18","author":"Lovell","year":"1997","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.mad.2024.111961_bib132","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.nurt.2010.05.014","article-title":"Microglial activation and chronic neurodegeneration","volume":"7","author":"Lull","year":"2010","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.mad.2024.111961_bib133","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-017-0150-7","article-title":"NADPH oxidase in brain injury and neurodegenerative disorders","volume":"12","author":"Ma","year":"2017","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.mad.2024.111961_bib134","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes","volume":"72","author":"MacDonald","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.mad.2024.111961_bib135","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/cns.12817","article-title":"Cause or compensation?\u2014Altered neuronal Ca2+ handling in Huntington\u2019s disease","volume":"24","author":"Mackay","year":"2018","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.mad.2024.111961_bib136","doi-asserted-by":"crossref","first-page":"4552","DOI":"10.1093\/hmg\/ddp421","article-title":"Mutant SOD1 in neuronal mitochondria causes toxicity and mitochondrial dynamics abnormalities","volume":"18","author":"Magran\u00e9","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.mad.2024.111961_bib137","article-title":"Mitochondria-targeted antioxidants protect against amyloid-\u03b2 toxicity in Alzheimer\u2019s disease neurons","volume":"20","author":"Manczak","year":"2010","journal-title":"J. Alzheimer\u2019S. Dis."},{"key":"10.1016\/j.mad.2024.111961_bib138","doi-asserted-by":"crossref","first-page":"37377","DOI":"10.1074\/jbc.M508246200","article-title":"Resveratrol promotes clearance of Alzheimer\u2019s disease amyloid-\u03b2 peptides","volume":"280","author":"Marambaud","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mad.2024.111961_bib139","first-page":"275","article-title":"Polymorphism of the fractalkine receptor CX3CR1 and systemic sclerosis-associated pulmonary arterial hypertension","volume":"12","author":"Marasini","year":"2005","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.mad.2024.111961_bib140","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1097\/01.jnen.0000248541.05552.c4","article-title":"Mitochondriopathy in Parkinson disease and amyotrophic lateral sclerosis","volume":"65","author":"Martin","year":"2006","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.mad.2024.111961_bib141","doi-asserted-by":"crossref","first-page":"839","DOI":"10.3390\/ph3040839","article-title":"Mitochondrial and cell death mechanisms in neurodegenerative diseases","volume":"3","author":"Martin","year":"2010","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.mad.2024.111961_bib142","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/nn.2528","article-title":"Cargo recognition failure is responsible for inefficient autophagy in Huntington\u2019s disease","volume":"13","author":"Martinez-Vicente","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.mad.2024.111961_bib143","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1385\/NMM:3:2:65","article-title":"Excitotoxic and excitoprotective mechanisms: abundant targets for the prevention and treatment of neurodegenerative disorders","volume":"3","author":"Mattson","year":"2003","journal-title":"NeuroMolecular Med."},{"key":"10.1016\/j.mad.2024.111961_bib144","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.arr.2014.12.011","article-title":"Lifelong brain health is a lifelong challenge: From evolutionary principles to empirical evidence","volume":"20","author":"Mattson","year":"2015","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.mad.2024.111961_bib145","doi-asserted-by":"crossref","first-page":"15179","DOI":"10.1073\/pnas.261400698","article-title":"Histone deacetylase inhibitors reduce polyglutamine toxicity","volume":"98","author":"McCampbell","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1016\/j.mad.2024.111961_bib146","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0304-3940(00)01701-8","article-title":"Proteasomal function is impaired in substantia nigra in Parkinson\u2019s disease","volume":"297","author":"McNaught","year":"2001","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.mad.2024.111961_bib147","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/srep42942","article-title":"Alpha-synuclein prevents the formation of spherical mitochondria and apoptosis under oxidative stress","volume":"7","author":"Menges","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.mad.2024.111961_bib148","doi-asserted-by":"crossref","first-page":"30773","DOI":"10.1074\/jbc.M504749200","article-title":"Mitochondrial respiration and ATP production are significantly impaired in striatal cells expressing mutant huntingtin","volume":"280","author":"Milakovic","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mad.2024.111961_bib149","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0165-6147(02)02020-5","article-title":"Analysis of exhaled breath condensate for monitoring airway inflammation","volume":"23","author":"Montuschi","year":"2002","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.mad.2024.111961_bib150","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.expneurol.2005.07.012","article-title":"CoQ10 therapy attenuates amyloid \u03b2-peptide toxicity in brain mitochondria isolated from aged diabetic rats","volume":"196","author":"Moreira","year":"2005","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.mad.2024.111961_bib151","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s40263-016-0317-8","article-title":"Advances in the Development of Disease-Modifying Treatments for Amyotrophic Lateral Sclerosis","volume":"30","author":"Moujalled","year":"2016","journal-title":"CNS Drugs"},{"key":"10.1016\/j.mad.2024.111961_bib152","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s007020050069","article-title":"Alzheimer\u2019s disease - Synergistic effects of glucose deficit, oxidative stress and advanced glycation endproducts","volume":"105","author":"M\u00fcnch","year":"1998","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.mad.2024.111961_bib153","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20081386","article-title":"How mitochondria produce reactive oxygen species","volume":"417","author":"Murphy","year":"2009","journal-title":"Biochem. J."},{"key":"10.1016\/j.mad.2024.111961_bib154","first-page":"165","article-title":"Amyotrophic Lateral Sclerosis","author":"Murray","year":"2014","journal-title":"Encycl. Neurol. Sci."},{"key":"10.1016\/j.mad.2024.111961_bib155","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.freeradbiomed.2004.04.037","article-title":"Effects of \u03b1-tocopherol on an animal model of tauopathies","volume":"37","author":"Nakashima","year":"2004","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.mad.2024.111961_bib156","doi-asserted-by":"crossref","first-page":"4094","DOI":"10.1007\/s12035-015-9337-5","article-title":"Oxidative Stress in Neurodegenerative Diseases","volume":"53","author":"Niedzielska","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.mad.2024.111961_bib157","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1093\/jnen\/60.8.759","article-title":"Oxidative damage is the earliest event in Alzheimer disease","volume":"60","author":"Nunomura","year":"2001","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.mad.2024.111961_bib158","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1523\/JNEUROSCI.0106-08.2008","article-title":"N-terminal mutant huntingtin associates with mitochondria and impairs mitochondrial trafficking","volume":"28","author":"Orr","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.mad.2024.111961_bib159","article-title":"Hereditary hyperekplexia","author":"Padberg","year":"2020","journal-title":"Definitions"},{"key":"10.1016\/j.mad.2024.111961_bib160","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/nrneurol.2015.57","article-title":"Amyotrophic lateral sclerosis: Mechanisms and therapeutics in the epigenomic era","volume":"11","author":"Paez-Colasante","year":"2015","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.mad.2024.111961_bib161","doi-asserted-by":"crossref","first-page":"42781","DOI":"10.1074\/jbc.M207601200","article-title":"ABCA1 and scavenger receptor class B, type I, are modulators of reverse sterol transport at an in vitro blood-brain barrier constituted of porcine brain capillary endothelial cells","volume":"277","author":"Panzenboeck","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mad.2024.111961_bib162","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fneur.2019.01315","article-title":"Therapeutic Applications of Cysteamine and Cystamine in Neurodegenerative and Neuropsychiatric Diseases","volume":"10","author":"Paul","year":"2019","journal-title":"Front. Neurol."},{"key":"10.1016\/j.mad.2024.111961_bib163","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1136\/jnnp.2007.128728","article-title":"Detection of Huntington\u2019s disease decades before diagnosis: the Predict-HD study","volume":"79","author":"Paulsen","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.mad.2024.111961_bib164","first-page":"1","article-title":"Parkinson disease","volume":"3","author":"Poewe","year":"2017","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.mad.2024.111961_bib165","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1001\/archneur.59.6.972","article-title":"Increase of brain oxidative stress in mild cognitive impairment: a possible predictor of Alzheimer disease","volume":"59","author":"Pratic\u00f2","year":"2002","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.mad.2024.111961_bib166","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.brainresbull.2009.07.010","article-title":"Role of mitochondrial dysfunction in the pathogenesis of Huntington\u2019s disease","volume":"80","author":"Quintanilla","year":"2009","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.mad.2024.111961_bib167","doi-asserted-by":"crossref","first-page":"26464","DOI":"10.1074\/jbc.R113.472936","article-title":"Peroxynitrite, a stealthy biological oxidant","volume":"288","author":"Radi","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mad.2024.111961_bib168","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1471-4159.2005.03530.x","article-title":"Amyloid precursor protein-mediated free radicals and oxidative damage: Implications for the development and progression of Alzheimer\u2019s disease","volume":"96","author":"Reddy","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.mad.2024.111961_bib169","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.drudis.2014.03.020","article-title":"Increased mitochondrial fission and neuronal dysfunction in Huntington\u2019s disease: Implications for molecular inhibitors of excessive mitochondrial fission","volume":"19","author":"Reddy","year":"2014","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.mad.2024.111961_bib170","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1111\/j.1582-4934.2008.00478.x","article-title":"Proteomic identification of nitrated brain proteins in early Alzheimer\u2019s disease inferior parietal lobule","volume":"13","author":"Reed","year":"2009","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.mad.2024.111961_bib171","doi-asserted-by":"crossref","unstructured":"R.J. Reiter, S.A. Rosales-Corral, D.X. Tan, D. Acuna-Castroviejo, L. Qin, S.F. Yang, K. Xu, Melatonin, a full service anti-cancer agent: Inhibition of initiation, progression and metastasis, 2017. \u3008https:\/\/doi.org\/10.3390\/ijms18040843\u3009.","DOI":"10.3390\/ijms18040843"},{"key":"10.1016\/j.mad.2024.111961_bib172","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.neuron.2011.09.010","article-title":"A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD","volume":"72","author":"Renton","year":"2011","journal-title":"Neuron"},{"issue":"80","key":"10.1016\/j.mad.2024.111961_bib173","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1126\/science.1130481","article-title":"H2O2, a necessary evil for cell signaling","volume":"312","author":"Rhee","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.mad.2024.111961_bib174","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.neulet.2009.11.056","article-title":"The effect of entrainment on the timing of periodic eye movements","volume":"469","author":"Richardson","year":"2010","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.mad.2024.111961_bib175","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1471-4159.1989.tb09150.x","article-title":"Transition metals, ferritin, glutathione, and ascorbic acid in Parkinsonian Brains","volume":"52","author":"Riederer","year":"1989","journal-title":"J. Neurochem"},{"key":"10.1016\/j.mad.2024.111961_bib176","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s00431-005-0015-x","article-title":"Congenital hyperekplexia: five sporadic cases","volume":"165","author":"Rivera","year":"2006","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.mad.2024.111961_bib177","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s004150050551","article-title":"Oxidative stress in amyotrophic lateral sclerosis","volume":"247","author":"Robberecht","year":"2000","journal-title":"J. Neurol. Suppl."},{"key":"10.1016\/j.mad.2024.111961_bib178","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/362059a0","article-title":"Mutations in Cu\/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis","volume":"362","author":"Rosen","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.mad.2024.111961_bib179","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1474-4422(10)70245-3","article-title":"Huntington\u2019s disease: from molecular pathogenesis to clinical treatment","volume":"10","author":"Ross","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.mad.2024.111961_bib180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0304-3940(03)00319-7","article-title":"In vivo micro magnetic resonance imaging signal changes in scrapie infected mice","volume":"345","author":"Sadowski","year":"2003","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.mad.2024.111961_bib181","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1179\/1743132812Y.0000000073","article-title":"Oxidative stress and inflammation biomarkers in the blood of patients with huntington\u2019s disease","volume":"34","author":"S\u00e1nchez-L\u00f3pez","year":"2012","journal-title":"Neurol. Res."},{"key":"10.1016\/j.mad.2024.111961_bib182","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/jnen\/60.2.161","article-title":"Early and progressive accumulation of reactive microglia in the Huntington disease brain","volume":"60","author":"Sapp","year":"2001","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.mad.2024.111961_bib183","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/ana.410420411","article-title":"Huntingtin localization in brains of normal and Huntington\u2019s disease patients","volume":"42","author":"Sapp","year":"1997","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.mad.2024.111961_bib184","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0005-2728(98)00164-9","article-title":"Mitochondrial involvement in Parkinson\u2019s disease, Huntington\u2019s disease, hereditary spastic paraplegia and Friedreich\u2019s ataxia","volume":"1410","author":"Schapira","year":"1999","journal-title":"Biochim. Biophys. Acta Bioenerg."},{"key":"10.1016\/j.mad.2024.111961_bib185","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S1474-4422(07)70327-7","article-title":"Mitochondria in the aetiology and pathogenesis of Parkinson\u2019s disease","volume":"7","author":"Schapira","year":"2008","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.mad.2024.111961_bib186","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/j.1471-4159.1990.tb02325.x","article-title":"Mitochondrial Complex I Deficiency in Parkinson\u2019s Disease","volume":"54","author":"Schapira","year":"1990","journal-title":"J. Neurochem."},{"key":"10.1016\/j.mad.2024.111961_bib187","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/sleep\/18.6.501","article-title":"An American sleep disorders association review oral appliances for the treatment of snoring and obstructive sleep Apnea: a review","volume":"18","author":"Schmidt-Nowara","year":"1995","journal-title":"Sleep"},{"key":"10.1016\/j.mad.2024.111961_bib188","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1172\/JCI200317741","article-title":"Neuronal degeneration and mitochondrial dysfunction","volume":"111","author":"Schon","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.mad.2024.111961_bib189","doi-asserted-by":"crossref","first-page":"595","DOI":"10.15252\/emmm.201606210","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease at 25 years","volume":"8","author":"Selkoe","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.mad.2024.111961_bib190","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/BF03161151","article-title":"Molecular factors underlying selective vulnerability of motor neurons to neurodegeneration in amyotrophic lateral sclerosis","volume":"247","author":"Shaw","year":"2000","journal-title":"J. Neurol. Suppl."},{"key":"10.1016\/j.mad.2024.111961_bib191","first-page":"1","article-title":"Circulating brain-enriched microRNAs as novel biomarkers for detection and differentiation of neurodegenerative diseases","volume":"9","author":"Sheinerman","year":"2017","journal-title":"Alzheimer\u2019S. Res. Ther."},{"key":"10.1016\/j.mad.2024.111961_bib192","doi-asserted-by":"crossref","first-page":"10756","DOI":"10.1523\/JNEUROSCI.23-34-10756.2003","article-title":"Mechanism of toxicity in rotenone models of Parkinson\u2019s disease","volume":"23","author":"Sherer","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.mad.2024.111961_bib193","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0304-3940(94)90956-3","article-title":"Cu Zn superoxide dismutase-like immunoreactivity in Lewy body-like inclusions of sporadic amyotrophic lateral sclerosis","volume":"179","author":"Shibata","year":"1994","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.mad.2024.111961_bib194","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1001\/archneur.59.10.1541","article-title":"Effects of coenzyme Q10 in Early Parkinson Disease","volume":"59","author":"Shults","year":"2002","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.mad.2024.111961_bib195","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/ana.410360305","article-title":"Alterations in glutathione levels in Parkinson\u2019s disease and other neurodegenerative disorders affecting basal ganglia","volume":"36","author":"Sian","year":"1994","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.mad.2024.111961_bib196","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.redox.2015.01.002","article-title":"Oxidative stress: a concept in redox biology and medicine","volume":"4","author":"Sies","year":"2015","journal-title":"Redox Biol."},{"key":"10.1016\/j.mad.2024.111961_bib197","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1212\/WNL.62.10.1758","article-title":"Increased lipid peroxidation in sera of ALS patients: a potential biomarker of disease burden","volume":"62","author":"Simpson","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.mad.2024.111961_bib198","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clnesp.2021.02.014","article-title":"Effects of vitamin supplements on clinical cardiovascular outcomes: Time to move on! - a comprehensive review","volume":"42","author":"Simsek","year":"2021","journal-title":"Clin. Nutr. Espen."},{"issue":"80","key":"10.1016\/j.mad.2024.111961_bib199","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1090278","article-title":"\u03b1-Synuclein locus triplication causes Parkinson\u2019s Disease","volume":"302","author":"Singleton","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.mad.2024.111961_bib200","first-page":"351","article-title":"Urate and Homocysteine: predicting motor and cognitive changes in newly diagnosed Parkinson\u2019s disease","volume":"9","author":"Sleeman","year":"2019","journal-title":"J. Park. Dis."},{"key":"10.1016\/j.mad.2024.111961_bib201","doi-asserted-by":"crossref","unstructured":"A.D. Smith, H. Refsum, Homocysteine, B Vitamins, and Cognitive Impairment, (n.d.). \u3008https:\/\/doi.org\/10.1146\/annurev-nutr-071715-050947\u3009.","DOI":"10.1146\/annurev-nutr-071715-050947"},{"key":"10.1016\/j.mad.2024.111961_bib202","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","article-title":"Toward defining the preclinical stages of Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"Sperling","year":"2011","journal-title":"Alzheimer\u2019S. Dement"},{"key":"10.1016\/j.mad.2024.111961_bib203","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00726-003-0011-2","article-title":"Free radical-mediated oxidation of free amino acids and amino acid residues in proteins","volume":"25","author":"Stadtman","year":"2003","journal-title":"Amino Acids"},{"key":"10.1016\/j.mad.2024.111961_bib204","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1073\/pnas.88.5.1646","article-title":"Ubiquinol-10 protects human low density lipoprotein more efficiently against lipid peroxidation than does \u03b1-tocopherol","volume":"88","author":"Stocker","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mad.2024.111961_bib205","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1073\/pnas.0400282101","article-title":"Decline in transcriptional activity of Nrf2 causes age-related loss of glutathione synthesis, which is reversible with lipoic acid","volume":"101","author":"Suh","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mad.2024.111961_bib206","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.neurobiolaging.2005.05.005","article-title":"Oxidative modification and down-regulation of Pin1 in Alzheimer\u2019s disease hippocampus: A redox proteomics analysis","volume":"27","author":"Sultana","year":"2006","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.mad.2024.111961_bib207","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.arr.2018.04.004","article-title":"Dysbiosis of gut microbiota and microbial metabolites in Parkinson\u2019s Disease","volume":"45","author":"Sun","year":"2018","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.mad.2024.111961_bib208","doi-asserted-by":"crossref","unstructured":"D.J. Surmeier, 1-s2.0-S1474442207702466-main.pdf, (2007) 933\u2013938.","DOI":"10.1016\/S1474-4422(07)70246-6"},{"key":"10.1016\/j.mad.2024.111961_bib209","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","article-title":"Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders","volume":"14","author":"Sweeney","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.mad.2024.111961_bib210","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.mehy.2003.12.045","article-title":"A \u201cmitochondrial cascade hypothesis\u201d for sporadic Alzheimer\u2019s disease","volume":"63","author":"Swerdlow","year":"2004","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.mad.2024.111961_bib211","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154757","article-title":"Involvement of antioxidant enzymes in Parkinson\u2019s disease","volume":"249","author":"Tahavvori","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.mad.2024.111961_bib212","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006296","article-title":"The genetics of Alzheimer disease","volume":"2","author":"Tanzi","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.mad.2024.111961_bib213","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3390\/jcm9041223","article-title":"Oxidative stress in neurodegenerative diseases: from preclinical studies to clinical applications","volume":"9","author":"Tarozzi","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.mad.2024.111961_bib214","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1136\/bmj.1.4455.815-a","article-title":"Paralysis AGitans:\u00a0a disclaimer","volume":"1","author":"Teller","year":"1946","journal-title":"Br. Med. J."},{"key":"10.1016\/j.mad.2024.111961_bib215","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1093\/brain\/awt355","article-title":"HTT-lowering reverses Huntington\u2019s disease immune dysfunction caused by NF\u03baB pathway dysregulation","volume":"137","author":"Tr\u00e4ger","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.mad.2024.111961_bib216","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2174\/157015909787602823","article-title":"P, Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options","volume":"7","author":"Uttara","year":"2009","journal-title":"Curr. Neuropharmacol."},{"issue":"80","key":"10.1016\/j.mad.2024.111961_bib217","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1126\/science.1096284","article-title":"Hereditary early-onset Parkinson\u2019s disease caused by mutations in PINK1","volume":"304","author":"Valente","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.mad.2024.111961_bib218","doi-asserted-by":"crossref","first-page":"3617","DOI":"10.1073\/pnas.0730423100","article-title":"Misfolded CuZnSOD and amyotrophic lateral sclerosis","volume":"100","author":"Valentine","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mad.2024.111961_bib219","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.biocel.2006.07.001","article-title":"Free radicals and antioxidants in normal physiological functions and human disease","volume":"39","author":"Valko","year":"2007","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.mad.2024.111961_bib220","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1179\/016164107X240099","article-title":"Mechanisms of brain edema in acute liver failure and impact of novel therapeutic interventions","volume":"29","author":"Vaquero","year":"2007","journal-title":"Neurol. Res."},{"key":"10.1016\/j.mad.2024.111961_bib221","doi-asserted-by":"crossref","first-page":"184","DOI":"10.4329\/wjr.v7.i8.184","article-title":"Updates in advanced diffusion-weighted magnetic resonance imaging techniques in the evaluation of prostate cancer","volume":"7","author":"Vargas","year":"2015","journal-title":"World J. Radiol."},{"key":"10.1016\/j.mad.2024.111961_bib222","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/molecules23102485","article-title":"Neuroprotective role of phytochemicals","volume":"23","author":"Velmurugan","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.mad.2024.111961_bib223","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","article-title":"Neuropathological classification of Huntington\u2019s disease","volume":"44","author":"Vonsattel","year":"1985","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.mad.2024.111961_bib224","article-title":"Protective effect of Que Zui Tea on d-galactose-induced oxidative stress damage in mice via regulating SIRT1\/Nrf2 signaling pathway","volume":"29","author":"Wang","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.mad.2024.111961_bib225","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.bbrc.2006.05.011","article-title":"Increased level of DJ-1 in the cerebrospinal fluids of sporadic Parkinson\u2019s disease","volume":"345","author":"Waragai","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.mad.2024.111961_bib226","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1089\/ars.2012.4827","article-title":"Redox reactions and microbial killing in the neutrophil phagosome","volume":"18","author":"Winterbourn","year":"2013","journal-title":"Antioxid. Redox Signal"},{"key":"10.1016\/j.mad.2024.111961_bib227","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13329","article-title":"NAD+ supplementation prevents STING-induced senescence in ataxia telangiectasia by improving mitophagy","volume":"20","author":"Yang","year":"2021","journal-title":"Aging Cell"},{"key":"10.1016\/j.mad.2024.111961_bib228","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/acel.13329","article-title":"NAD+ supplementation prevents STING-induced senescence in ataxia telangiectasia by improving mitophagy","volume":"20","author":"Yang","year":"2021","journal-title":"Aging Cell"},{"key":"10.1016\/j.mad.2024.111961_bib229","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.freeradbiomed.2019.05.037","article-title":"NEIL1 stimulates neurogenesis and suppresses neuroinflammation after stress","volume":"141","author":"Yang","year":"2019","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.mad.2024.111961_bib230","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.freeradbiomed.2019.05.037","article-title":"NEIL1 stimulates neurogenesis and suppresses neuroinflammation after stress","volume":"141","author":"Yang","year":"2019","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.mad.2024.111961_bib231","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/BF02257619","article-title":"Mitochondrial complex I and II activities of lymphocytes and platelets in Parkinson\u2019s disease","volume":"4","author":"Yoshino","year":"1992","journal-title":"J. Neural Transm. Park. Dis. Dement. Sect."},{"key":"10.1016\/j.mad.2024.111961_bib232","doi-asserted-by":"crossref","first-page":"9843","DOI":"10.1073\/pnas.0403495101","article-title":"The role of iron and molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during aging","volume":"101","author":"Zecca","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mad.2024.111961_bib233","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/nrn1537","article-title":"Iron, brain ageing and neurodegenerative disorders","volume":"5","author":"Zecca","year":"2004","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.mad.2024.111961_bib234","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0047-6374(01)00342-6","article-title":"Differential activation of neuronal ERK, JNK\/SAPK and p38 in Alzheimer disease: the \u201ctwo hit\u201d hypothesis","volume":"123","author":"Zhu","year":"2001","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.mad.2024.111961_bib235","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.neuron.2004.11.005","article-title":"Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology","volume":"44","author":"Zimprich","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.mad.2024.111961_bib236","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nrneurol.2009.54","article-title":"Brain-derived neurotrophic factor in neurodegenerative diseases","volume":"5","author":"Zuccato","year":"2009","journal-title":"Nat. Rev. Neurol."}],"container-title":["Mechanisms of Ageing and Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0047637424000617?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0047637424000617?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T11:26:56Z","timestamp":1725881216000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0047637424000617"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":236,"alternative-id":["S0047637424000617"],"URL":"https:\/\/doi.org\/10.1016\/j.mad.2024.111961","relation":{},"ISSN":["0047-6374"],"issn-type":[{"value":"0047-6374","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New opportunities for antioxidants in amelioration of neurodegenerative diseases","name":"articletitle","label":"Article Title"},{"value":"Mechanisms of Ageing and Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mad.2024.111961","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111961"}}